ARNUITY Trademark

Trademark Overview

On Thursday, November 1, 2012, a trademark application was filed for ARNUITY with the United States Patent and Trademark Office. The USPTO has given the ARNUITY trademark a serial number of 85769233. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, April 28, 2022. This trademark is owned by Glaxo Group Limited. The ARNUITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
arnuity

General Information

Serial Number85769233
Word MarkARNUITY
Filing DateThursday, November 1, 2012
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, April 28, 2022
Registration Number4872584
Registration DateTuesday, December 22, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 7, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Tuesday, June 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 28, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, April 28, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, April 28, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 10, 2021TEAS SECTION 8 & 15 RECEIVED
Tuesday, December 22, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 22, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, September 23, 20151(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, August 26, 2015NOTICE OF ALLOWANCE CANCELLED
Wednesday, August 26, 2015TEAS DELETE 1(B) BASIS RECEIVED
Friday, June 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 4, 2015SOU EXTENSION 4 GRANTED
Tuesday, May 19, 2015SOU EXTENSION 4 FILED
Tuesday, May 19, 2015TEAS EXTENSION RECEIVED
Thursday, October 30, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 29, 2014SOU EXTENSION 3 GRANTED
Wednesday, October 22, 2014SOU EXTENSION 3 FILED
Wednesday, October 22, 2014TEAS EXTENSION RECEIVED
Thursday, May 1, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 30, 2014SOU EXTENSION 2 GRANTED
Thursday, April 10, 2014SOU EXTENSION 2 FILED
Wednesday, April 30, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 10, 2014TEAS EXTENSION RECEIVED
Saturday, October 26, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 24, 2013SOU EXTENSION 1 GRANTED
Thursday, October 24, 2013SOU EXTENSION 1 FILED
Thursday, October 24, 2013TEAS EXTENSION RECEIVED
Tuesday, June 4, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 9, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2013PUBLISHED FOR OPPOSITION
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 20, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 1, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 27, 2013ASSIGNED TO LIE
Friday, February 15, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 15, 2013EXAMINER'S AMENDMENT ENTERED
Friday, February 15, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 15, 2013EXAMINERS AMENDMENT E-MAILED
Friday, February 15, 2013EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 13, 2013ASSIGNED TO EXAMINER
Wednesday, November 7, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 5, 2012NEW APPLICATION ENTERED

Related Keywords

arnuity pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological